» Articles » PMID: 16244522

Alternatives to Endotracheal Intubation for Patients with Neuromuscular Diseases

Overview
Date 2005 Oct 26
PMID 16244522
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the usefulness of continuous noninvasive mechanical ventilation and mechanical coughing aids to avoid endotracheal intubation and tracheostomy during episodes of acute respiratory failure in patients with neuromuscular disease.

Design: We conducted a prospective cohort study at the respiratory medicine ward of a university hospital to study the success rate of the use of continuous noninvasive mechanical ventilation and manually and mechanically (CoughAssist) assisted coughing to avert endotracheal intubation in 24 consecutive episodes of acute respiratory failure for 17 patients with neuromuscular disease. The noninvasive mechanical ventilation and coughing aids were used to reverse decreases in oxyhemoglobin saturation and relieve respiratory distress that occurred despite oxygen therapy and appropriate medication. Noninvasive mechanical ventilation was delivered by volume ventilators (Breas PV 501) alternating nasal/oronasal and oral interfaces.

Results: Noninvasive management was successful in averting death and endotracheal intubation in 79.2% of the acute episodes. There were no significant differences in respiratory function between the successfully treated and unsuccessfully treated groups before the current episode. Bulbar dysfunction was the independent risk factor for failure of noninvasive treatment (P < 0.05; odds ratio, 35.99%; 95% confidence interval, 1.71-757.68).

Conclusions: Intubation can be avoided for some patients with neuromuscular disease in acute respiratory failure by some combination of noninvasive mechanical ventilation and mechanically assisted coughing. Severe bulbar involvement can limit the effectiveness of noninvasive management.

Citing Articles

Respiratory support effect on pharyngeal area in patients with amyotrophic lateral sclerosis: A fluoroscopic comparison of NIV, helmet/CPAP, and high-flow nasal cannula.

Dorca A, Vergara J, Skoretz S, Brenner M, Diniz D, Zeredo J Respir Med Case Rep. 2024; 46:101958.

PMID: 38187117 PMC: 10770539. DOI: 10.1016/j.rmcr.2023.101958.


The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study.

Lionello F, Lapia F, Molena B, Padoan A, Lococo S, Arcaro G J Clin Med. 2023; 12(18).

PMID: 37763001 PMC: 10531616. DOI: 10.3390/jcm12186061.


The role of lung volume recruitment therapy in neuromuscular disease: a narrative review.

Sheers N, OSullivan R, Howard M, Berlowitz D Front Rehabil Sci. 2023; 4:1164628.

PMID: 37565183 PMC: 10410160. DOI: 10.3389/fresc.2023.1164628.


Emergencies cards for neuromuscular disorders 1 Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report.

Racca F, Sansone V, Ricci F, Filosto M, Pedroni S, Mazzone E Acta Myol. 2023; 41(4):135-177.

PMID: 36793651 PMC: 9896597. DOI: 10.36185/2532-1900-081.


Management of Critically Ill Patients With Spinal Muscular Atrophy Admitted With Acute Respiratory Failure.

Al-Subu A, Adams C, Dykstra S, Langkamp M, Yngsdal-Krenz R, Al Subu R Respir Care. 2023; 68(2):247-254.

PMID: 36596652 PMC: 9994271. DOI: 10.4187/respcare.10353.